Literature DB >> 14303250

METABOLISM OF 17-BETA-OESTRADIOL-4-14-C IN EARLY INFANCY.

A A HAGEN, M BARR, E DICZFALUSY.   

Abstract

Entities:  

Keywords:  ABNORMALITIES; CARBON ISOTOPES; CHROMATOGRAPHY; ESTRADIOL; ESTRIOL; ESTROGENS; HYDROXYLASES; INFANT, NEWBORN; METABOLISM; URINE

Mesh：

Substances：

Year:  1965        PMID： 14303250

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  12 in total

1.  Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton.

Authors:  Maria Silvia Giretti; Maria Magdalena Montt Guevara; Elena Cecchi; Paolo Mannella; Giulia Palla; Stefania Spina; Guja Bernacchi; Silvia Di Bello; Andrea Riccardo Genazzani; Alessandro D Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-26       Impact factor: 5.555

2.  Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.

Authors:  Ingrid J M Duijkers; Christine Klipping; Yvette Zimmerman; Nicole Appels; Maud Jost; Catherine Maillard; Marie Mawet; Jean-Michel Foidart; Herjan J T Coelingh Bennink
Journal:  Eur J Contracept Reprod Health Care       Date:  2015       Impact factor: 1.848

3.  Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells.

Authors:  Wei Yue; Carole Verhoeven; Herjan Coelingh Bernnink; Ji-Ping Wang; Richard J Santen
Journal:  Breast Cancer (Auckl)       Date:  2019-05-15

Review 4.  Estetrol and Mammary Gland: Friends or Foes?

Authors:  Anne Gallez; Isabelle Dias Da Silva; Vincent Wuidar; Jean-Michel Foidart; Christel Péqueux
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-08-31       Impact factor: 2.673

Review 5.  Estetrol: A New Choice for Contraception.

Authors:  Franca Fruzzetti; Tiziana Fidecicchi; Maria Magdalena Montt Guevara; Tommaso Simoncini
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

6.  Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.

Authors:  Anne Gallez; Silvia Blacher; Erik Maquoi; Erika Konradowski; Marc Joiret; Irina Primac; Céline Gérard; Mélanie Taziaux; René Houtman; Liesbet Geris; Françoise Lenfant; Elisabetta Marangoni; Nor Eddine Sounni; Jean-Michel Foidart; Agnès Noël; Christel Péqueux
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

7.  Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells.

Authors:  Maria Magdalena Montt-Guevara; Maria Silvia Giretti; Eleonora Russo; Andrea Giannini; Paolo Mannella; Andrea Riccardo Genazzani; Alessandro David Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2015-07-22       Impact factor: 5.555

8.  The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.

Authors:  Anne Abot; Coralie Fontaine; Mélissa Buscato; Romain Solinhac; Gilles Flouriot; Aurélie Fabre; Anne Drougard; Shyamala Rajan; Muriel Laine; Alain Milon; Isabelle Muller; Daniel Henrion; Marine Adlanmerini; Marie-Cécile Valéra; Anne Gompel; Céline Gerard; Christel Péqueux; Mélanie Mestdagt; Isabelle Raymond-Letron; Claude Knauf; François Ferriere; Philippe Valet; Pierre Gourdy; Benita S Katzenellenbogen; John A Katzenellenbogen; Françoise Lenfant; Geoffrey L Greene; Jean-Michel Foidart; Jean-François Arnal
Journal:  EMBO Mol Med       Date:  2014-10       Impact factor: 12.137

9.  Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms.

Authors:  Céline Gérard; Mélanie Mestdagt; Ekaterine Tskitishvili; Laudine Communal; Anne Gompel; Elisabete Silva; Jean-François Arnal; Françoise Lenfant; Agnès Noel; Jean-Michel Foidart; Christel Péqueux
Journal:  Oncotarget       Date:  2015-07-10

10.  Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi).

Authors:  Herjan J T Coelingh Bennink; Jeroen A van Moorselaar; E David Crawford; Erik P M Roos; Diederik M Somford; Ton A Roeleveld; Tjard D de Haan; Harm H E van Melick; Yacov Reisman; Yvette Zimmerman; Gonnie van Osta; Jan Krijgh; Neal D Shore; Fred Saad; Andrew V Schally; Frans M J Debruyne
Journal:  Eur Urol Open Sci       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.